Healthcare

Nearly 8 in 10 employers report that GLP-1s are driving an increase in their company's health care costs.

A hospital bill would have to show whether the care was delivered on the main campus or at an outpatient facility.

The research shows that the barrier to health often is relatively small—typically less than $1,500.

The opening sessions of this year's BenefitsPRO Broker Expo in Chicago kicked off with one of the year's hottest topics: GLP-1 drugs.

"Employees aren't disengaged because they don't care; instead it's because benefits are too hard to navigate," said Jonathan Porter, CEO of Castlight Health.

A Pharmaceutical Strategies Group survey finds employers and health plans prioritizing cost control and cross-benefit management, with growing willingness to trade rebates for stronger utilization oversight amid rising complexity and CGT concerns.